The Opti-2 Clinical Trial Is Complete

This study aimed to evaluate the efficacy, safety, and tolerability of HDV-Insulin. If you have questions about the trial or are looking for information regaurding the trial, please reach out to +1.216.444.7110 or contact us via info@diasome.com